Bio-Rad Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0905722072
USD
259.02
1.9 (0.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
592.10
693.20
653.00
651.60
585.40
667.50
649.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
592.10
693.20
653.00
651.60
585.40
667.50
649.73
Raw Material Cost
282.70
348.40
310.20
306.20
274.80
312.40
293.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.30
12.10
12.30
12.60
12.00
12.20
12.17
Selling and Distribution Expenses
212.40
216.90
205.80
205.10
193.50
202.50
200.44
Other Expenses
5.06
5.39
5.83
4.82
4.82
5.56
4.89
Total Expenditure (Excl Depreciation)
558.00
631.30
586.60
572.10
528.50
582.70
555.36
Operating Profit (PBDIT) excl Other Income
34.1
61.900000000000006
66.39999999999999
79.5
56.900000000000006
84.80000000000001
94.39999999999999
Other Income
26.60
30.70
12.60
15.10
39.90
21.40
16.44
Operating Profit (PBDIT)
111.30
145.00
133.20
145.20
145.00
155.50
159.91
Interest
12.30
12.10
12.30
12.60
12.00
12.20
12.17
Exceptional Items
-738.20
848.70
-497.80
332.00
-1.40
-1,002.90
762.99
Gross Profit (PBDT)
309.40
344.80
342.80
345.40
310.60
355.10
355.90
Depreciation
50.60
52.40
54.20
50.60
48.20
49.30
49.10
Profit Before Tax
-689.80
929.20
-431.10
414.00
83.40
-908.90
861.62
Tax
-162.70
209.20
-89.20
96.20
19.40
-193.10
208.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-527.10
720.00
-341.90
317.80
64.00
-715.80
653.17
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-527.10
720.00
-341.90
317.80
64.00
-715.80
653.17
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-527.10
720.00
-341.90
317.80
64.00
-715.80
653.17
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,851.30
7,453.60
6,736.80
7,128.70
6,679.40
6,569.30
7,487.86
Earnings per share (EPS)
-19.55
26.65
-12.7
11.67
2.29
-25.57
23.34
Diluted Earnings per share
-19.55
26.65
-12.7
11.67
2.29
-25.57
23.34
Operating Profit Margin (Excl OI)
5.76%
8.93%
10.17%
12.2%
9.72%
12.7%
14.52%
Gross Profit Margin
-107.95%
141.6%
-57.72%
71.3%
22.48%
-128.78%
140.17%
PAT Margin
-89.02%
103.87%
-52.36%
48.77%
10.93%
-107.24%
100.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -14.58% vs 6.16% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -173.21% vs 310.59% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -25.90% vs -5.22% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 1.65% vs -1.63% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Bio-Rad Laboratories, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
592.10
540.42
51.68
9.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
592.10
540.42
51.68
9.56%
Raw Material Cost
282.70
217.43
65.27
30.02%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.30
10.14
2.16
21.30%
Selling and Distribution Expenses
212.40
153.88
58.52
38.03%
Other Expenses
5.06
3.71
1.35
36.39%
Total Expenditure (Excl Depreciation)
558.00
418.54
139.46
33.32%
Operating Profit (PBDIT) excl Other Income
34.10
121.88
-87.78
-72.02%
Other Income
26.60
20.10
6.50
32.34%
Operating Profit (PBDIT)
111.30
191.37
-80.07
-41.84%
Interest
12.30
10.14
2.16
21.30%
Exceptional Items
-738.20
-22.67
-715.53
-3,156.29%
Gross Profit (PBDT)
309.40
322.99
-13.59
-4.21%
Depreciation
50.60
49.39
1.21
2.45%
Profit Before Tax
-689.80
109.17
-798.97
-731.86%
Tax
-162.70
1.34
-164.04
-12,241.79%
Provisions and contingencies
0
0
0.00
Profit After Tax
-527.10
107.83
-634.93
-588.83%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-527.10
107.83
-634.93
-588.83%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-527.10
107.83
-634.93
-588.83%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,851.30
3,778.15
3,073.15
81.34%
Earnings per share (EPS)
-19.55
0.52
-20.07
-3,859.62%
Diluted Earnings per share
-19.55
0.52
-20.07
-3,859.62%
Operating Profit Margin (Excl OI)
5.76%
22.55%
0.00
-16.79%
Gross Profit Margin
-107.95%
29.34%
0.00
-137.29%
PAT Margin
-89.02%
19.95%
0.00
-108.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 59.21 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.58% vs 6.16% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.14% vs -4.16% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -52.71 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -173.21% vs 310.59% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -923.59% vs -83.33% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.47 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -25.90% vs -5.22% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -19.41% vs 5.31% in Mar 2025

Quarterly - Interest
Interest 1.23 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.65% vs -1.63% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.50% vs -2.44% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.76%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025